title: Low calcium dialysate combined with CaCO3in hyperphosphatemia in hemodialysis patients.
abstract: This aim of this study was to observe the effects of the application of low calcium dialysate (LCD) combined with oral administration of CaCO3in the treatment of hyperphosphatemia, as well as blood Ca2+, calcium-phosphate product (CPP), parathyroid hormone (PTH) and blood pressure in patients undergoing hemodialysis. Thirty-one maintenance hemodialysis (MHD) patients with hyperphosphatemia, but normal blood Ca2+, underwent dialysis with an initial dialy-sate Ca2+concentration (DCa) of 1.50 mmol/l for six months and then with 1.25 mmol/l for six months. The patients who underwent dialysis with a DCa of 1.25 mmol/l were treated orally with 0.3 g CaCO3tablets three times a day. In the third and sixth months [observation end point (OEP)] of the dialysis, the concentrations of Ca2+, phosphorus and intact PTH (iPTH) were measured; blood pressure and side-effects prior to and following dialysis were also observed. The Ca2+, CPP and iPTH levels increased (P<0.05) in the sixth month of treatment with a DCa of 1.50 mmol/l. However, the Ca2+concentration declined to a certain degree, CPPs decreased significantly (P<0.05) and the iPTH concentration increased following treatment with a DCa of 1.25 mmol/l for six months. The incidence rate of adverse effects of LCD was 12.9% (4/31); the effects were mainly muscle spasms, hypotension and elevated PTH. The periodic application of LCD combined with the oral administration of CaCO3effectively reduced serum phosphorus and CPPs among MHD patients with hyperphosphatemia, indicating that the treatment may be used clinically.
authors.affiliation: Department of Nephrology, Air Force General Hospital, Beijing 100142, P.R. China.
authors.forename: Zhuo
authors.initials: Z
authors.lastname: Gao
authors.forename: Li-DE
authors.initials: LD
authors.lastname: Lun
authors.forename: Xin-Lun
authors.initials: XL
authors.lastname: Li
keywords: calcium-phosphate product; hyperphosphatemia; low calcium dialysis; parathyroid hormone